Division of Musculoskeletal Biology I, Institute of Ageing and Chronic Disease, Faculty of Health and Life Science, University of Liverpool, Liverpool, UK Medical Research Institute, University of Dundee, Dundee, UK Aberdeen Pain Research Collaboration (Musculoskeletal Research), Division of Applied Medicine, University of Aberdeen, Aberdeen, UK University of Dundee, Health Informatics Centre, Dundee, UK BHF Glasgow Cardiovascular Research Centre, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, UK Molecular and Clinical Pharmacology, Faculty of Health and Life Science, University of Liverpool, Liverpool, UK.
Pain. 2013 Sep;154(9):1595-1602. doi: 10.1016/j.pain.2013.04.043. Epub 2013 May 7.
To explore whether chronic pain is associated with cardiovascular risk factors and identify whether increased distribution or intensity of pain is associated with cardiovascular risk, participants in Generation Scotland: The Scottish Family Health study completed pain questionnaires recording the following: presence of chronic pain, distribution of pain, and intensity of chronic pain. Blood pressure, lipids, blood glucose, smoking history, waist-hip ratio, and body mass index were recorded; Framingham 10-year coronary heart disease (CHD) risk scores were calculated and a diagnosis of metabolic syndrome derived. Associations between chronic pain and cardiovascular risk were explored. Of 13,328 participants, 1100 (8.3%) had high CHD risk. Chronic pain was reported by 5209 (39%), 1294 (9.7%) reported widespread chronic pain, and 707 (5.3%) reported high-intensity chronic pain. In age- and gender-adjusted analyses, chronic pain was associated with elevated CHD risk scores (odds ratio 1.11, 95% confidence interval 1.01-1.23) and the metabolic syndrome (odds ratio 1.42, 95% confidence interval 1.24-1.62). Multivariate analyses identified dyslipidaemia, age, gender, smoking, obesity, and high waist-hip ratio as independently associated with chronic pain. Within the chronic pain subgroup, widespread pain did not confer any additional cardiovascular disease risk. However, cardiovascular disease risk factors contributing to metabolic syndrome were more prevalent in those reporting high-intensity chronic pain. This large population-based study has demonstrated that chronic pain, and in particular high-intensity chronic pain, is associated with an increased prevalence of cardiovascular risk factors and metabolic syndrome. The 10-year CHD risk score and metabolic syndrome correlate well with increased pain intensity, but not with widespread pain.
为了探究慢性疼痛是否与心血管危险因素相关,并确定疼痛分布或强度的增加是否与心血管风险相关,苏格兰家族健康研究(Generation Scotland: The Scottish Family Health study)的参与者完成了疼痛问卷,记录了以下内容:慢性疼痛的存在、疼痛的分布以及慢性疼痛的强度。同时还记录了血压、血脂、血糖、吸烟史、腰臀比和体重指数;计算了弗雷明汉 10 年冠心病(CHD)风险评分,并得出代谢综合征的诊断。探讨了慢性疼痛与心血管风险之间的关联。在 13328 名参与者中,有 1100 人(8.3%)具有高 CHD 风险。5209 人(39%)报告有慢性疼痛,1294 人(9.7%)报告有广泛的慢性疼痛,707 人(5.3%)报告有高强度的慢性疼痛。在年龄和性别调整分析中,慢性疼痛与升高的 CHD 风险评分(比值比 1.11,95%置信区间 1.01-1.23)和代谢综合征(比值比 1.42,95%置信区间 1.24-1.62)相关。多变量分析确定血脂异常、年龄、性别、吸烟、肥胖和高腰臀比与慢性疼痛独立相关。在慢性疼痛亚组中,广泛疼痛不会增加任何额外的心血管疾病风险。然而,导致代谢综合征的心血管疾病危险因素在报告高强度慢性疼痛的人群中更为普遍。这项基于人群的大型研究表明,慢性疼痛,特别是高强度慢性疼痛,与心血管危险因素和代谢综合征的患病率增加相关。10 年 CHD 风险评分和代谢综合征与疼痛强度增加密切相关,但与广泛疼痛无关。